Abstract:Purpose: Chronic musculoskeletal pain (CMP) is defined as persistent or recurrent pain that occurs in the joints, musculo-soft tissue, spine or bones for more than three months and is not completely curable. Although topical Chinese patent medicine (CPM) is the most extensively utilized medication in Asia and is widely used for pain management, its efficacy remains controversial. This article presents a systematic review of clinical studies on the therapeutic properties of topical CPM for CMP patients to better inform clinical decision-making and provide additional and safer treatment options for patients with CMP. Method: We performed a comprehensive search on PubMed, Cochrane Library, web of science and Chinese databases (CNKI and WanFang data) from 2010 to 2022. In all the studies, knee osteoarthritis, cervical spondylosis, low back pain, and periarthritis of shoulder met the International Pain Association definition of chronic musculoskeletal pain. We included only randomized controlled trials (RCTs) using topical CPM primarily for chronic musculoskeletal pain in adults. To determine the effect of topical CPM on clinical symptoms, we extracted the Visual Analog Scale (VAS, range 0-10) and the Western Ontario and McMaster Universities Arthritis Index pain scores (WOMAC pain, range 0-20), in which the lower the score, the better the results. We also accepted the comprehensive outcome criteria developed by the Chinese National Institute of Rheumatology as an endpoint (total effectiveness rate, range 0-100%, higher score = better outcome), which assesses the overall pain, physical function and wellness. Finally, trial sequential analysis of VAS pain score and total effectiveness rate was performed using TSA software. Results: Twenty-six randomized controlled trials (n = 3180 participants) compared topical CPM with oral Nonsteroidal Anti-inflammatory Drugs (NSAIDs) (n = 15), topical NSAIDs (n = 9), physiotherapy (n = 5), exercise therapy (n = 4), and intra-articular Sodium hyaluronate injection (n = 2). Sixteen studies found that topical CPM was statistically significant in improving CMP pain (measured by VAS pain and Womac pain scores)(p < 0.05), and 12 studies found topical CPMs to be more clinically effective (assessed by ≥ 30% reduction in symptom severity) in treating patients with CMP (p < 0.05). Trial sequential analysis indicates that the current available evidence is robust, and further studies cannot reverse this result. In most of the studies, randomisation, allocation concealment and blinding were not sufficiently described, and no placebo-controlled trials were identified. Conclusion: Most studies showed superior analgesic effects of topical CPM over various control treatments, suggesting that topical CPM may be effective for CMP and is an additional, safe and reasonable treatment option. These reported benefits should be validated in higher-quality RCTs.

Interpretation of "Expert consensus of the Chinese Association for the Study of Pain on pain treatment with the transdermal patch"

Expert consensus of the Chinese Association for the Study of Pain on pain treatment with the transdermal patch

Expert Consensus on the Treat-to-target Strategy for Psoriasis with Biological Agents in China

Experts consensus on minimally invasive therapy techniques for the treatment of pain related to posterior ramus of spinal nerve in China (2021)

Expert Consensus of Chinese Association for the Study of Pain on the Non-Opioid Analgesics for Chronic Musculoskeletal Pain

Expert consensus on tibial nerve block therapy in China (2023 edition)

Pain Management of Patients underwent Transradial Coronary Intervention Therapy

Interpretation of Application of Glucocorticoids in Minimally Invasive Interventional Treatment for Pain (chinese Expert Consensus):The Severe Side Effects Induced by Glucocorticoids in Epidural Injection and Its Prevention

Clinical application of extracorporeal shock wave therapy: a consensus of Chinese painology expert (2023 edition)

Interpretation of “chinese Expert Concensus on the Clinical Application of Compound Opioid Analgesics (2018 Edition)”

Chinese Association for the Study of Pain: Experts Consensus on Ultrasound-Guided Injections for the Treatment of Spinal Pain in China (2020 Edition)

Topical Chinese patent medicines for chronic musculoskeletal pain: systematic review and trial sequential analysis

A Chinese guideline for the treatment of chronic musculoskeletal pain disease with Chinese patent medicine (2023 edition)

Pain management with transdermal drug administration: A review

Is the Use of a Buprenorphine Transdermal Patch More Effective Than Oral Medications for Postoperative Analgesia After Arthroscopic Rotator Cuff Repair? A Randomized Clinical Trial

Expert consensus on the ultrasound-guided injection for the treatment of spinal pain in China(2020)

Multicenter Clinical Study for Evaluation of Efficacy and Safety of Transdermal Fentanyl Matrix Patch in Treatment of Moderate to Severe Cancer Pain in 474 Chinese Cancer Patients

Preference of Orthopedic Practitioners Toward the Use of Topical Medicine for Musculoskeletal Pain Management in China: A National Survey

Interpretation of Chinese experts' consensus on clinical application of methadone in cancer pain

Expert consensus on clinical application of Wangbi Tablets in treating rheumatoid arthritis and knee osteoarthritis

Transdermal buprenorphine patch as an adjunct to multimodal analgesia after total joint arthroplasty: a retrospective cohort study